The following two dose levels will be tested sequentially:~4.1E11 total vg/cochlea~8.1E11 total vg/cochlea
Part A of this trial will evaluate the safety and tolerability of a single unilateral administration of one of two dose levels of AAVAnc80-hOTOF and will evaluate the Akouos delivery device to safely achieve the intended product performance.